Leishmaniasis epidemiology in endemic areas of metropolitan France and its overseas territories from 1998 to 2020.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
received:
21
11
2021
accepted:
16
08
2022
revised:
01
11
2022
pubmed:
8
10
2022
medline:
4
11
2022
entrez:
7
10
2022
Statut:
epublish
Résumé
In France, leishmaniasis is endemic in the Mediterranean region, in French Guiana and to a lesser extent, in the French West Indies. This study wanted to provide an updated picture of leishmaniasis epidemiology in metropolitan France and in its overseas territories. Leishmaniasis cases were collected by passive notification to the French National Reference Centre for Leishmaniases (NRCL) in Montpellier from 1998 to 2020 and at the associated Centre in Cayenne (French Guiana) from 2003 to 2020. In metropolitan France, 517 autochthonous leishmaniasis cases, mostly visceral forms due to Leishmania infantum (79%), and 1725 imported cases (French Guiana excluded), mainly cutaneous leishmaniasis from Maghreb, were recorded. A slight decrease of autochthonous cases was observed during the survey period, from 0.48 cases/100,000 inhabitants per year in 1999 (highest value) to 0.1 cases/100,000 inhabitants per year in 2017 (lowest value). Conversely, imported cases increased over time (from 59.7 in the 2000s to 94.5 in the 2010s). In French Guiana, 4126 cutaneous and mucocutaneous leishmaniasis cases were reported from 2003 to 2020. The mean incidence was 103.3 cases per 100,000 inhabitants/year but varied in function of the year (from 198 in 2004 to 54 in 2006). In Guadeloupe and Martinique (French West Indies), only sporadic cases were reported. Because of concerns about disease expansion and outbreaks in other Southern Europe countries, and leishmaniasis monitoring by the NRCL should be continued and associated with a more active surveillance.
Sections du résumé
BACKGROUND
In France, leishmaniasis is endemic in the Mediterranean region, in French Guiana and to a lesser extent, in the French West Indies. This study wanted to provide an updated picture of leishmaniasis epidemiology in metropolitan France and in its overseas territories.
METHODOLOGY/PRINCIPAL FINDINGS
Leishmaniasis cases were collected by passive notification to the French National Reference Centre for Leishmaniases (NRCL) in Montpellier from 1998 to 2020 and at the associated Centre in Cayenne (French Guiana) from 2003 to 2020. In metropolitan France, 517 autochthonous leishmaniasis cases, mostly visceral forms due to Leishmania infantum (79%), and 1725 imported cases (French Guiana excluded), mainly cutaneous leishmaniasis from Maghreb, were recorded. A slight decrease of autochthonous cases was observed during the survey period, from 0.48 cases/100,000 inhabitants per year in 1999 (highest value) to 0.1 cases/100,000 inhabitants per year in 2017 (lowest value). Conversely, imported cases increased over time (from 59.7 in the 2000s to 94.5 in the 2010s). In French Guiana, 4126 cutaneous and mucocutaneous leishmaniasis cases were reported from 2003 to 2020. The mean incidence was 103.3 cases per 100,000 inhabitants/year but varied in function of the year (from 198 in 2004 to 54 in 2006). In Guadeloupe and Martinique (French West Indies), only sporadic cases were reported.
CONCLUSIONS/SIGNIFICANCE
Because of concerns about disease expansion and outbreaks in other Southern Europe countries, and leishmaniasis monitoring by the NRCL should be continued and associated with a more active surveillance.
Identifiants
pubmed: 36206322
doi: 10.1371/journal.pntd.0010745
pii: PNTD-D-21-01654
pmc: PMC9624409
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0010745Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Microbiol. 2021 Jan 21;59(2):
pubmed: 33148706
Am J Trop Med Hyg. 2013 Sep;89(3):564-9
pubmed: 23939706
Lancet. 2002 Aug 3;360(9330):374-9
pubmed: 12241778
BMJ. 1991 Aug 10;303(6798):336-8
pubmed: 1912774
Clin Microbiol Rev. 2008 Apr;21(2):334-59, table of contents
pubmed: 18400800
Acta Trop. 2011 Aug;119(2-3):69-75
pubmed: 21679680
Euro Surveill. 2013 Jul 18;18(29):20534
pubmed: 23929121
Parasit Vectors. 2010 Apr 08;3:31
pubmed: 20377867
PLoS One. 2012;7(5):e35671
pubmed: 22693548
Lancet. 2018 Sep 15;392(10151):951-970
pubmed: 30126638
Emerg Infect Dis. 2012 Jun;18(6):1030
pubmed: 22607725
Parasitology. 2002 Sep;125(Pt 3):197-207
pubmed: 12358417
Ann Trop Med Parasitol. 2001 Sep;95(6):623-5
pubmed: 11672468
Trop Med Health. 2017 Feb 28;45:5
pubmed: 28265182
PLoS Negl Trop Dis. 2012;6(8):e1765
pubmed: 22880142
Presse Med. 2013 Nov;42(11):1469-81
pubmed: 23886932
J Clin Microbiol. 2004 Sep;42(9):4077-82
pubmed: 15364993
Parasite. 2014;21:12
pubmed: 24626346
PLoS Negl Trop Dis. 2011 Nov;5(11):e1407
pubmed: 22140590
Am J Trop Med Hyg. 1990 Jul;43(1):25-8
pubmed: 2200289
Clin Infect Dis. 2016 Dec 15;63(12):e202-e264
pubmed: 27941151
PLoS Negl Trop Dis. 2020 Aug 14;14(8):e0008380
pubmed: 32797078
Trans R Soc Trop Med Hyg. 1989 Sep-Oct;83(5):616-20
pubmed: 2617622
PLoS Negl Trop Dis. 2016 Feb 22;10(2):e0004458
pubmed: 26900688
Parasitology. 2011 Dec;138(14):1878-91
pubmed: 21914251
J Travel Med. 2014 Mar-Apr;21(2):116-29
pubmed: 24745041
Vaccine. 2007 May 22;25(21):4223-34
pubmed: 17395339
Am J Trop Med Hyg. 2015 Feb;92(2):317-9
pubmed: 25404076
Int J Dermatol. 2019 Nov;58(11):1323-1328
pubmed: 31524286